ViewPoint Therapeutics
Latest round
- Series B
Last raised
- Mar 2018
Total raised
- $39M
Investors
- 7
About ViewPoint Therapeutics
ViewPoint Therapeutics is engaged in the research and development of therapies aimed at treating ocular diseases. The company was founded in 2014 and is headquartered in San Francisco, California. In September 2022, ViewPoint was acquired by Visus Therapeutics, which will leverage ViewPoint’s extensive library of drug candidates for ocular delivery.ViewPoint Therapeutics develops innovative drug candidates for treating ocular diseases, emphasizing advanced drug delivery mechanisms.Following its acquisition by Visus Therapeutics, ViewPoint Therapeutics is expected to further advance its pipeline of ocular drug candidates. The financial infusion from the acquisition will enable the development of new products targeting ocular conditions. Plans for expansion into additional therapeutic areas may also be explored in the coming years as the company aligns with Visus Therapeutics' broader strategy.
Who invested in ViewPoint Therapeutics
7 investors across 2 rounds
See all investors in ViewPoint Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ViewPoint Therapeutics
Who invested in ViewPoint Therapeutics?
ViewPoint Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ViewPoint Therapeutics raised?
ViewPoint Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ViewPoint Therapeutics last raise money?
ViewPoint Therapeutics's most recent round on record is a Series B, in Mar 2018.
What does ViewPoint Therapeutics do?
ViewPoint Therapeutics is engaged in the research and development of therapies aimed at treating ocular diseases.
Where is ViewPoint Therapeutics headquartered?
ViewPoint Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like ViewPoint Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ViewPoint Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ViewPoint Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.